KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 14 filers reported holding KAZIA THERAPEUTICS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $189,000 | -33.2% | 22,425 | -10.2% | 0.00% | – |
| Q3 2021 | $283,000 | -56.4% | 24,975 | -62.1% | 0.00% | -100.0% |
| Q2 2021 | $649,000 | +129.3% | 65,823 | +188.2% | 0.00% | – |
| Q1 2021 | $283,000 | -58.9% | 22,840 | -71.3% | 0.00% | -100.0% |
| Q4 2020 | $688,000 | +31.5% | 79,625 | +2.7% | 0.00% | 0.0% |
| Q3 2020 | $523,000 | +133.5% | 77,525 | +17.3% | 0.00% | – |
| Q2 2020 | $224,000 | +126.3% | 66,066 | +93.0% | 0.00% | – |
| Q1 2020 | $99,000 | -36.5% | 34,225 | -4.5% | 0.00% | – |
| Q4 2019 | $156,000 | +20.9% | 35,856 | +4.5% | 0.00% | – |
| Q3 2019 | $129,000 | +44.9% | 34,325 | 0.0% | 0.00% | – |
| Q2 2019 | $89,000 | -22.6% | 34,325 | 0.0% | 0.00% | – |
| Q1 2019 | $115,000 | +38.6% | 34,325 | 0.0% | 0.00% | – |
| Q4 2018 | $83,000 | -23.9% | 34,325 | 0.0% | 0.00% | – |
| Q3 2018 | $109,000 | -63.1% | 34,325 | -50.0% | 0.00% | – |
| Q2 2018 | $295,000 | +52.8% | 68,650 | +100.0% | 0.00% | – |
| Q1 2018 | $193,000 | +77.1% | 34,325 | 0.0% | 0.00% | – |
| Q4 2017 | $109,000 | – | 34,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 99,180 | $857,000 | 0.09% |
| HighPoint Advisor Group LLC | 32,435 | $368,000 | 0.04% |
| Transform Wealth, LLC | 106,245 | $95,000 | 0.02% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 19,600 | $170,000 | 0.00% |
| Renaissance Technologies | 79,625 | $688,000 | 0.00% |
| TRUIST FINANCIAL CORP | 35,260 | $304,000 | 0.00% |
| UBS Group AG | 2,851 | $25,000 | 0.00% |
| BREWIN DOLPHIN LTD | 32 | $276 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 5 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,800 | $24,000 | 0.00% |